Paul Ginocchio - Feb 23, 2024 Form 4 Insider Report for Augmedix, Inc. (AUGX)

Role
CHIEF FINANCIAL OFFICER
Signature
/s/ Todd Holvick, Attorney-in-Fact
Stock symbol
AUGX
Transactions as of
Feb 23, 2024
Transactions value $
$0
Form type
4
Date filed
2/27/2024, 08:31 PM
Previous filing
Nov 27, 2023
Next filing
May 17, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AUGX Restricted Stock Units Award $0 +100K $0.00 100K Feb 23, 2024 Common Stock 100K Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Issuer's common stock.
F2 The RSU is granted under the Augmedix, Inc. (the "Issuer") 2020 Equity Incentive Plan. One-sixteenth (1/16th) of the RSU will vest quarterly in equal increments over four (4) years commencing on 02/15/2024, with the first one-sixteenth (1/16th) vesting on 5/15/2024, subject to the Reporting Person's provision of service to the Issuer on each vesting date.